CHRISTINA HAYEK: Open Payments
NPI 1972927853 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,457 in 118 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $3,082 · 2025 $2,457
Food & beverage: $2,457
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $439 |
| ABBVIE INC. | 20 | $345 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| Merck Sharp & Dohme LLC | 7 | $177 |
| Celgene Corporation | 10 | $154 |
| Janssen Biotech, Inc. | 6 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $131 |
| Daiichi Sankyo Inc. | 5 | $117 |
| Aveo Pharmaceuticals, Inc. | 3 | $93 |
| Eisai Inc. | 3 | $77 |
Products named: LIBTAYO, REBLOZYL, KEYTRUDA, Enhertu, VENCLEXTA, EPKINLY, FOTIVDA, RYBREVANT.
Industry payments across NY — which companies pay providers there.
